FEATURED ARTICLES

• Custom Solutions For Efficient Buffer Management

  Learn about the services that helped four companies ramp up their mAb production despite complications when it comes to hydration and buffer prep.

• Enhance Virus Clearance Process Capability With Biodegradable Detergent

  Learn more about an effective, biodegradable solution for the viral inactivation process that controls protein impurities and is compatible with downstream unit operations.

• Outsourcing Manufacturing Of Acetic Acid And Benzyl Alcohol Solutions

  Custom buffer solutions produced for a multinational biopharmaceutical company, enabled a fast facility expansion while still meeting the customers strict quality and regulatory requirements.

• Overcoming Risk In Cell And Gene Production

  To meet the speed to market demands of today requires process standardization and portability, improvements in raw material supply and sourcing and greater supply chain control.

• AI Improving Inventory Management For Single-Use Systems Manufacturing

  The use of AI and machine learning tools can begin the process of moving from predictive, human-driven inventory management and manufacturing processes to genuine, data-driven decision making

• Fixing Stability And Other Viral Vector Challenges

  Stable and standardized viral vector workflows are essential for getting transformative, customized cell and gene therapy treatments to patients. Read about a collaborative problem-solving approach for viral vector production.

• Solving Challenges In Gene Therapy Scale-Up & Manufacturing

  Avantor EVP of biopharma production Dr. Ger Brophy offers insight into lessons learned from manufacturing mAbs or vaccines, improving supplier collaboration, and other factors.

• Why cGMP Chemicals And Single-Use Technologies Are Critical

  Ensuring transformative medicines make it to patients in need, requires risk mitigation strategies that improve the quality of raw materials while facilitating scale-up processes to meet global demand.

• Achieve Downstream Process Improvements Through Buffer Management

  Understanding the alternative buffer management and preparation strategies available can ensure you have the tools and resources to remain competitive in today’s growing bioprocessing industry.

• Opportunities And Challenges In Cell And Gene Therapy Development

  Dr. Ger Brophy, EVP, Biopharma Production at Avantor, gives his perspective on cell and gene therapy, one of the most revolutionary trends driving the biopharma sector. 

• Single-Use Technology: Critical To Cell And Gene Therapy Commercialization

  Scaling up cell and gene therapies from R&D to commercialization creates challenges for manufacturers, but single-use solutions for in-process sampling can help.

• Global Single-Use Supply Chains: Managing Risk, Minimizing Complexity

  Biopharma manufacturers can benefit by adopting a global single-use supply chain strategy early in the drug development life cycle and carefully evaluating their single-use equipment and materials suppliers.